Sign In
Buy RLYB
$16.07
-0.160 (-0.99%)
At Close: Jun 03, 2026
Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
08:00am, Tuesday, 08'th Apr 2025
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial
08:00am, Tuesday, 11'th Feb 2025
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio Highlights 2024 Accomplishments and Anticipated Milestones for 2025
08:00am, Friday, 10'th Jan 2025
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting
08:00am, Tuesday, 10'th Dec 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025
08:00am, Monday, 02'nd Dec 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference
08:00am, Tuesday, 26'th Nov 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor
08:00am, Monday, 25'th Nov 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212
08:00am, Thursday, 21'st Nov 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis
08:00am, Thursday, 29'th Aug 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
Rallybio to Present at Upcoming Investor Conferences
08:00am, Tuesday, 27'th Aug 2024
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati
National Vision Releases 2023 Sustainability Report
08:00am, Tuesday, 27'th Aug 2024
DULUTH, Ga.--(BUSINESS WIRE)--National Vision, Inc., one of the largest optical retail companies in the U.S., released its 2023 Sustainability Report, “A World Worth Seeing.” The report reflects c
Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Wednesday, 14'th Aug 2024
Rallybio (RLYB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
4 Stocks Under $5 To Buy Now
01:05pm, Thursday, 08'th Aug 2024
Are you looking for stocks to buy with low price tags?
